How do patterns of progression influence treatment selection after chemohormonal therapy in patients with metastatic hormone sensitive prostate cancer?

被引：1
|
作者：
De La Rosa, Carlos Aguado
Carbonero, Iciar Garcia
De Velasco, Guillermo
Alonso, Teresa
Villalobos, Maria L.
Garrido, Maria
Gallegos, Isabel
Martin, Almudena
Pinto, Alvaro
Alonso, Constanza Maximiano
Rodriguez-Moreno, J. F.
Rodriguez, Laura
Sereno, Maria
Perezagua, Carmen
Marrupe, David
Riquelme, Alejandro
Cassinello, Javier
Grande, Enrique
Puente, Javier
Gajate, Pablo
机构：
[1] Hosp Univ Clin San Carlos, Madrid, Spain
[2] Hosp Virgen Salud, Toledo, Spain
[3] Hosp Univ 12 Octubre, Madrid, Spain
[4] Hosp Univ Ramon y Cajal, Madrid, Spain
[5] Hosp Univ Principe Asturias, Madrid, Spain
[6] Hosp Univ Severo Ochoa, Madrid, Spain
[7] Hosp Gen Segovia, Segovia, Spain
[8] Hosp Infanta Leonor, Madrid, Spain
[9] Hosp Univ La Paz, Madrid, Spain
[10] Hosp Univ Puerta Hierro, Madrid, Spain
[11] Ctr Integral Oncol Clara Campal, Madrid, Spain
[12] Hosp Univ Fuenlabrada, Fuenlabrada, Spain
[13] Hosp Univ Infanta Sofia, Madrid, Spain
[14] Hosp Univ Henares, Coslada, Spain
[15] Hosp Univ Mostoles, Mostoles, Spain
[16] Hosp Univ Infanta Cristina, Parla, Spain
[17] Hosp Univ Guadalajara, Guadalajara, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e16504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16504
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Metastatic Hormone-sensitive Prostate Cancer: Patient Selection for Prostate Radiotherapy
    Chakrabarti, Deep
    Parker, Chris C.
    EUROPEAN UROLOGY, 2024, 86 (01) : 18 - 19
  • [32] Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
    Bryce, Alan H.
    Chen, Yu Hui
    Liu, Glenn
    Carducci, Michael A.
    Jarrard, David M.
    Garcia, Jorge A.
    Dreicer, Robert
    Hussain, Maha
    Eisenberger, Mario Alfredo
    Plimack, Elizabeth R.
    Vogelzang, Nicholas J.
    DiPaola, Robert S.
    Harshman, Lauren
    Sweeney, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (06): : 717 - 724
  • [33] Treatment of metastatic hormone-sensitive prostate cancer: from doublet therapy to triplet therapy
    Ye, Shi-jie
    Huang, Rui-da
    Fei, Xin
    Tao, Zhu-lei
    Liu, Wei-hua
    Ma, Qi
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1188) : 703 - 708
  • [34] Influence of cardiovascular (CV) comorbidities on the selection of hormone deprivation therapy (HDT) in the treatment of metastatic prostate cancer (mPCa).
    Lehmann, Jan
    Flesch, Markus
    Vosgerau, Sebastian
    Gedamke, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [35] Triple therapy in metastatic hormone-sensitive prostate cancer
    Tsaur, Igor
    Mirvald, Cristian
    Surcel, Cristian
    CURRENT OPINION IN UROLOGY, 2023, 33 (06) : 452 - 457
  • [36] Systemic therapy in metastatic hormone-sensitive prostate cancer
    McDonald, Jodie
    O'Brien, Jonathan
    Kostos, Louise
    Lawrentschuk, Nathan
    Azad, Arun A.
    Murphy, Declan
    Chen, Kenneth
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 234 - 239
  • [37] Triplet Therapy: Entering the Metaverse of Metastatic Hormone-sensitive Prostate Cancer Treatment
    Dzimitrowicz, Hannah E.
    Armstrong, Andrew J.
    EUROPEAN UROLOGY, 2022, 82 (06) : 599 - 601
  • [38] NATIONAL TREATMENT UTILIZATION PATTERNS FOR PATIENTS WITH METASTATIC CASTRATE SENSITIVE PROSTATE CANCER
    Sheckley, Fahad
    Nguyen, Jennifer
    Iarajuli, Teona
    Stifelman, Michael
    Yerram, Nitin
    JOURNAL OF UROLOGY, 2023, 209 : E265 - E265
  • [39] Treatment of primary cancer in metastatic hormone-sensitive prostate cancer
    Lim, Kylie Y. -Y.
    Alberto, Matthew
    Ranasinghe, Weranja
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (04) : 315 - 323
  • [40] Metastatic hormone sensitive prostate cancer: local treatment strategies
    Walz, Jochen
    Pignot, Geraldine
    Fakhfakh, Sami
    Campagna, Jennifer
    Guerin, Mathilde
    Vicier, Cecile
    Brunelle, Serge
    Salem, Naji
    Gravis, Gwenaelle
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 327 - 337
12345